Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Reza Esfandiary

Showing results (11-20 of 39) with videos related to

Pageof 4
Sort By:
Mabs|April 7, 2016
Mitigation of reversible self-association and viscosity in a human IgG1 monoclonal antibody by rational, structure-guided Fv engineeringJames C Geoghegan, Ryan Fleming, Melissa Damschroder, et al.
Mabs|August 8, 2025
Enhanced rational protein engineering to reduce viscosity in high-concentration IgG1 antibody solutionsTyler J Lefevre, Jenna G Caldwell, Austin Gallegos, et al.
Molecular Pharmaceutics|September 6, 2021
Visible Light Degradation of a Monoclonal Antibody in a High-Concentration Formulation: Characterization of a Tryptophan-Derived Chromophoric Photo-product by Comparison to Photo-degradation of <i>N</i>-Acetyl-l-tryptophan AmideIndira Prajapati, Nicholas R Larson, Sureshkumar Choudhary, et al.
Journal of Pharmaceutical Sciences|June 16, 2019
Characterization of Excipient Effects on Reversible Self-Association, Backbone Flexibility, and Solution Properties of an IgG1 Monoclonal Antibody at High Concentrations: Part 1Yue Hu, Jayant Arora, Sangeeta B Joshi, et al.
Journal of Pharmaceutical Sciences|October 28, 2022
Conformational Changes and Drivers of Monoclonal Antibody Liquid-Liquid Phase SeparationNicholas R Larson, Yangjie Wei, Thayana Araújo Cruz, et al.
Journal of Pharmaceutical Sciences|February 18, 2016
Improved Comparative Signature Diagrams to Evaluate Similarity of Storage Stability Profiles of Different IgG1 mAbsJae Hyun Kim, Sangeeta B Joshi, Reza Esfandiary, et al.
Journal of Pharmaceutical Sciences|January 24, 2014
Structural characterization of IgG1 mAb aggregates and particles generated under various stress conditionsSrivalli N Telikepalli, Ozan S Kumru, Cavan Kalonia, et al.
Mabs|December 20, 2014
Correlations between changes in conformational dynamics and physical stability in a mutant IgG1 mAb engineered for extended serum half-lifeRanajoy Majumdar, Reza Esfandiary, Steven M Bishop, et al.
Journal of Pharmaceutical Sciences|June 14, 2019
Characterization of Excipient Effects on Reversible Self-Association, Backbone Flexibility, and Solution Properties of an IgG1 Monoclonal Antibody at High Concentrations: Part 2Yue Hu, Ronald T Toth, Sangeeta B Joshi, et al.
Journal of Pharmaceutical Sciences|September 17, 2010
Formulation and immunogenicity studies of type III secretion system needle antigens as vaccine candidatesBrooke S Barrett, Aaron P Markham, Reza Esfandiary, et al.
Pageof 4

Showing results (11-20 of 39) with videos related to

Sort By:
Pageof 4
Mabs|April 7, 2016
Mitigation of reversible self-association and viscosity in a human IgG1 monoclonal antibody by rational, structure-guided Fv engineeringJames C Geoghegan, Ryan Fleming, Melissa Damschroder, et al.
Mabs|August 8, 2025
Enhanced rational protein engineering to reduce viscosity in high-concentration IgG1 antibody solutionsTyler J Lefevre, Jenna G Caldwell, Austin Gallegos, et al.
Molecular Pharmaceutics|September 6, 2021
Visible Light Degradation of a Monoclonal Antibody in a High-Concentration Formulation: Characterization of a Tryptophan-Derived Chromophoric Photo-product by Comparison to Photo-degradation of <i>N</i>-Acetyl-l-tryptophan AmideIndira Prajapati, Nicholas R Larson, Sureshkumar Choudhary, et al.
Journal of Pharmaceutical Sciences|June 16, 2019
Characterization of Excipient Effects on Reversible Self-Association, Backbone Flexibility, and Solution Properties of an IgG1 Monoclonal Antibody at High Concentrations: Part 1Yue Hu, Jayant Arora, Sangeeta B Joshi, et al.
Journal of Pharmaceutical Sciences|October 28, 2022
Conformational Changes and Drivers of Monoclonal Antibody Liquid-Liquid Phase SeparationNicholas R Larson, Yangjie Wei, Thayana Araújo Cruz, et al.
Journal of Pharmaceutical Sciences|February 18, 2016
Improved Comparative Signature Diagrams to Evaluate Similarity of Storage Stability Profiles of Different IgG1 mAbsJae Hyun Kim, Sangeeta B Joshi, Reza Esfandiary, et al.
Journal of Pharmaceutical Sciences|January 24, 2014
Structural characterization of IgG1 mAb aggregates and particles generated under various stress conditionsSrivalli N Telikepalli, Ozan S Kumru, Cavan Kalonia, et al.
Mabs|December 20, 2014
Correlations between changes in conformational dynamics and physical stability in a mutant IgG1 mAb engineered for extended serum half-lifeRanajoy Majumdar, Reza Esfandiary, Steven M Bishop, et al.
Journal of Pharmaceutical Sciences|June 14, 2019
Characterization of Excipient Effects on Reversible Self-Association, Backbone Flexibility, and Solution Properties of an IgG1 Monoclonal Antibody at High Concentrations: Part 2Yue Hu, Ronald T Toth, Sangeeta B Joshi, et al.
Journal of Pharmaceutical Sciences|September 17, 2010
Formulation and immunogenicity studies of type III secretion system needle antigens as vaccine candidatesBrooke S Barrett, Aaron P Markham, Reza Esfandiary, et al.
Pageof 4